Hepatitis A Vaccine
1995
Hepatitis A Vaccine Overview
Editorial
Author Information
Author(s): Sebastian Faro, M.D., Ph.D.
Conclusion
The development and administration of a hepatitis A vaccine could significantly reduce the incidence of the disease.
Supporting Evidence
- Hepatitis A infections often resolve without serious consequences.
- The vaccine has been shown to be safe and effective in producing antibodies.
- Booster doses can lead to protective antibodies lasting over 20 years.
Takeaway
Hepatitis A is a disease that can be prevented with a vaccine, and vaccinating more people could help stop its spread.
Limitations
The strategy of vaccinating only high-risk groups has not been effective in reducing hepatitis B infections.
Participant Demographics
Groups recommended for vaccination include children, military personnel, homosexual men, injection-drug users, day-care workers, health-care workers, sewage-treatment workers, and food handlers.
Want to read the original?
Access the complete publication on the publisher's website